Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 10
2005 6
2006 8
2007 8
2008 6
2009 11
2010 13
2011 6
2012 6
2013 14
2014 12
2015 14
2016 8
2017 14
2018 21
2019 23
2020 20
2021 18
2022 12
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Tasleem M, Pelletier J, Sévigny J, Hussain Z, Khan A, Al-Harrasi A, El-Kott AF, Taslimi P, Negm S, Shafiq Z, Iqbal J. Tasleem M, et al. Among authors: sevigny j. Int J Biol Macromol. 2024 May;266(Pt 2):131068. doi: 10.1016/j.ijbiomac.2024.131068. Epub 2024 Mar 24. Int J Biol Macromol. 2024. PMID: 38531526
Extracellular nucleotides in smooth muscle contraction.
Babou Kammoe RB, Sévigny J. Babou Kammoe RB, et al. Among authors: sevigny j. Biochem Pharmacol. 2024 Feb;220:116005. doi: 10.1016/j.bcp.2023.116005. Epub 2023 Dec 22. Biochem Pharmacol. 2024. PMID: 38142836 Review.
Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) - a promising target for the immunotherapy of cancer.
Lopez V, Schuh HJM, Mirza S, Vaaßen VJ, Schmidt MS, Sylvester K, Idris RM, Renn C, Schäkel L, Pelletier J, Sévigny J, Naggi A, Scheffler B, Lee SY, Bendas G, Müller CE. Lopez V, et al. Among authors: sevigny j. Front Immunol. 2023 Aug 29;14:1173634. doi: 10.3389/fimmu.2023.1173634. eCollection 2023. Front Immunol. 2023. PMID: 37711611 Free PMC article.
Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression.
Rubenich DS, de Souza PO, Omizzollo N, Aubin MR, Basso PJ, Silva LM, da Silva EM, Teixeira FC, Gentil GFS, Domagalski JL, Cunha MT, Gadelha KA, Diel LF, Gelsleichter NE, Rubenich AS, Lenz GS, de Abreu AM, Kroeff GM, Paz AH, Visioli F, Lamers ML, Wink MR, Worm PV, Araújo AB, Sévigny J, Câmara NOS, Ludwig N, Braganhol E. Rubenich DS, et al. Among authors: sevigny j. Front Immunol. 2023 May 24;14:1183465. doi: 10.3389/fimmu.2023.1183465. eCollection 2023. Front Immunol. 2023. PMID: 37292196 Free PMC article.
222 results